Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SUPER-refractory Status Epilepticus After Cardiac Arrest: a Multicenter, Retrospective, Cohort Study of Dual Anti-glutamate Therapy With Ketamine and Perampanel

NCT05756621 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT05756621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05756621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SUPER-refractory Status Epilepticus After Cardiac Arrest: a Multicenter, Retrospective, Cohort Study of Dual Anti-glutamate Therapy With Ketamine and Perampanel
Lead sponsor
University of Milano Bicocca
Phase
Observational
Overall status
Completed
Start date
January 15, 2022
Completion date
December 31, 2025
Enrollment
84 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest, status epilepticus